Lindbrook Capital LLC Acquires 38 Shares of Axon Enterprise, Inc. (NASDAQ:AXON)

Lindbrook Capital LLC raised its holdings in shares of Axon Enterprise, Inc. (NASDAQ:AXON) by 18.3% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 246 shares of the biotechnology company’s stock after purchasing an additional 38 shares during the quarter. Lindbrook Capital LLC’s holdings in Axon Enterprise were worth $146,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also bought and sold shares of the business. Asset Dedication LLC increased its stake in Axon Enterprise by 11.3% during the 4th quarter. Asset Dedication LLC now owns 178 shares of the biotechnology company’s stock valued at $106,000 after purchasing an additional 18 shares in the last quarter. Bleakley Financial Group LLC increased its stake in Axon Enterprise by 1.3% during the 4th quarter. Bleakley Financial Group LLC now owns 1,527 shares of the biotechnology company’s stock valued at $908,000 after purchasing an additional 20 shares in the last quarter. Venturi Wealth Management LLC increased its stake in Axon Enterprise by 2.7% during the 4th quarter. Venturi Wealth Management LLC now owns 802 shares of the biotechnology company’s stock valued at $477,000 after purchasing an additional 21 shares in the last quarter. Insigneo Advisory Services LLC increased its stake in Axon Enterprise by 1.4% during the 3rd quarter. Insigneo Advisory Services LLC now owns 1,568 shares of the biotechnology company’s stock valued at $627,000 after purchasing an additional 22 shares in the last quarter. Finally, Menard Financial Group LLC increased its stake in Axon Enterprise by 0.8% during the 3rd quarter. Menard Financial Group LLC now owns 3,014 shares of the biotechnology company’s stock valued at $1,204,000 after purchasing an additional 24 shares in the last quarter. Institutional investors own 79.08% of the company’s stock.

Analysts Set New Price Targets

Several analysts have recently issued reports on the stock. Northcoast Research lowered shares of Axon Enterprise from a “buy” rating to a “neutral” rating in a research note on Wednesday, February 19th. JMP Securities reiterated an “outperform” rating on shares of Axon Enterprise in a research note on Tuesday, February 4th. TD Cowen assumed coverage on shares of Axon Enterprise in a research note on Wednesday, January 8th. They issued a “buy” rating and a $700.00 target price for the company. Needham & Company LLC reiterated a “buy” rating and issued a $600.00 target price on shares of Axon Enterprise in a research note on Wednesday, February 26th. Finally, Northland Securities upped their target price on shares of Axon Enterprise from $365.00 to $550.00 and gave the stock an “outperform” rating in a research note on Monday, November 11th. Three analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the company’s stock. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $587.38.

Insider Buying and Selling at Axon Enterprise

In other Axon Enterprise news, insider Jeffrey C. Kunins sold 1,370 shares of the company’s stock in a transaction dated Tuesday, December 17th. The shares were sold at an average price of $639.14, for a total transaction of $875,621.80. Following the sale, the insider now directly owns 125,950 shares of the company’s stock, valued at $80,499,683. This represents a 1.08 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, Director Caitlin Elizabeth Kalinowski sold 450 shares of the company’s stock in a transaction dated Thursday, January 2nd. The shares were sold at an average price of $604.07, for a total transaction of $271,831.50. Following the sale, the director now directly owns 6,929 shares in the company, valued at approximately $4,185,601.03. This trade represents a 6.10 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 5,146 shares of company stock valued at $3,262,847 over the last three months. 6.10% of the stock is currently owned by insiders.

Axon Enterprise Price Performance

Shares of NASDAQ:AXON opened at $526.40 on Friday. The company’s 50-day moving average is $601.11 and its 200 day moving average is $527.38. The company has a debt-to-equity ratio of 0.32, a quick ratio of 2.63 and a current ratio of 2.96. The company has a market capitalization of $40.14 billion, a P/E ratio of 136.02, a price-to-earnings-growth ratio of 5.17 and a beta of 1.12. Axon Enterprise, Inc. has a fifty-two week low of $273.52 and a fifty-two week high of $715.99.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.